Clearside Biomedical, Inc. (Nasdaq: CLSD) ("Clearside” or the "Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space ...
The combined companies will operate under the name Kalaris Therapeutics, Inc. and expects to report initial data from part 1 ...
Incorporate omega-3s into your diet: Foods like fish have been shown to reduce the risk of macular degeneration. Don’t forget to add a handful of walnuts to your meals as they’re also packed with ...
Kalaris is focused on developing TH103, a novel, differentiated anti-VEGF agent engineered to potentially provide longer-lasting and increased anti-VEGF activity to treat neovascular and exudative dis ...
The investigators retrospectively evaluated 126 consecutive treatment-naïve nAMD patients (126 eyes) who received a loading ...
Kalaris is focused on developing TH103, a novel, differentiated anti-VEGF agent engineered to potentially provide longer-lasting and increased ...
Interesting Engineering on MSN11d
US supercomputer with 200,000 trillion moves per second shows how DNA repairs itselfScientists have tapped into the Summit supercomputer to study an elaborate molecular pathway called nucleotide excision ...
Open’s bonnet, takes a deep breath and says, “It will cost you.” Scientists have harnessed the Summit supercomputer's raw ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback